Web of Pharma · Validation Lifecycle · GMP Quality Systems

Revalidation in Pharmaceuticals: When Is It Required?

A practical, risk-based guide to event-driven revalidation, periodic review, equipment requalification, process changes, and audit-ready GMP decisions.

Event-based triggers Periodic review Process and equipment Protocol and report control

Revalidation in Pharmaceuticals: When Is It Required?

Quick
answer

Revalidation is required when evidence shows that a validated process, facility, utility, equipment item, cleaning system, analytical method, or computerized system may no longer remain in its approved state. The trigger may be a significant change, an adverse trend, a repeated failure, a transfer or scale-up, a major repair, a regulatory commitment, or a risk-based periodic review. The extent can range from documented assessment and targeted testing to a full repeat of qualification or process performance studies.

DetectIdentify changes, failures, trends, or new knowledge that could affect the validated state.

AssessUse quality risk management to judge impact, scope, and the evidence needed.

TestExecute approved qualification, validation, monitoring, or verification activities.

ControlDocument the decision, update procedures, and maintain the validated state through lifecycle review.

A validated state is not a permanent certificate. It is a controlled conclusion supported by current process knowledge, qualified equipment, reliable data, and evidence that critical quality attributes remain consistently achieved. When the process, equipment, facility, material, software, method, or operating context changes, the original evidence may no longer fully represent routine production.

Revalidation is the structured response to that uncertainty. It prevents a common GMP mistake: repeating every validation study on an arbitrary calendar while overlooking a major change that occurred last month. A mature program combines event-based assessment, continued process monitoring, deviation and trend review, and a documented periodic review of the validated state.

This article explains when revalidation is required, when it is not automatically required, how to classify triggers, how to design a proportionate protocol, and how to close the decision with traceable evidence. It connects revalidation to the wider Process Validation in Pharmaceuticals lifecycle and the controls expected under cGMP.

What Is Revalidation in Pharmaceuticals?

Revalidation is the documented activity used to demonstrate that a previously validated process, system, facility, utility, equipment item, method, or cleaning program continues to operate within approved requirements after a change, event, periodic review, or new risk information. It may confirm the complete original scope or only the affected part of the system.

The decision is not simply “validate again” or “do nothing.” A defensible conclusion may be:

No revalidation required

The assessment shows no impact on critical quality attributes, critical process parameters, validated ranges, data integrity, or control strategy. The rationale is documented and approved.

Targeted revalidation

Only the affected equipment function, parameter range, cleaning step, analytical attribute, software module, or process stage needs additional evidence.

Full revalidation

The change or failure alters the process design, control strategy, product risk, or system boundary enough to require a broad repeat of qualification or performance evidence.

Key principle: revalidation is a risk-based lifecycle decision, not a ritual exercise. The protocol scope should be justified by the potential impact on product quality, patient safety, process capability, and data reliability.

Revalidation versus related terms

Term	Meaning	Typical decision question
Qualification	Documented evidence that a facility, utility, equipment item, or system is designed, installed, operates, or performs as intended.	Does the asset meet its approved requirements?
Validation	Documented evidence that a process or method consistently produces a result meeting predefined requirements.	Does the process or method reliably achieve its intended outcome?
Requalification	Repeat or partial qualification of an existing asset after change, relocation, repair, degradation, or a planned review.	Is the qualified state still demonstrated after the event?
Revalidation	Repeat or partial validation of an existing process, cleaning strategy, method, or computerized system after an impact trigger.	Does the original validation evidence remain representative?
Verification	Confirmation, often through routine monitoring or testing, that an approved requirement continues to be met.	Does ongoing evidence show the system remains in control?

When Is Revalidation Required?

Revalidation is generally required when a planned or unplanned event could change the validated assumptions, control strategy, critical quality attributes, critical process parameters, or the ability to generate reliable evidence. The following triggers should enter the formal change-control, deviation, CAPA, or periodic-review workflow.

Trigger	Why it may require revalidation	Possible evidence
Process or formulation change	New operating ranges, excipient level, API form, dosage strength, order of addition, mixing time, granulation endpoint, or drying profile may alter CQAs.	Risk assessment, development data, engineering batch, targeted PPQ, CPV trend, or full process study.
Equipment replacement or major modification	Capacity, geometry, contact material, control logic, heat transfer, mixing pattern, or automation may differ from the validated configuration.	DQ review, IQ/OQ/PQ, calibration, equivalence assessment, engineering runs, and process-performance evidence.
Facility, room, or utility change	HVAC, water, compressed gas, clean steam, electrical supply, pressure cascade, temperature, or humidity can affect product or process control.	Commissioning, qualification, mapping, environmental monitoring, utility testing, and affected-process assessment.
Scale-up, scale-down, or technology transfer	Heat and mass transfer, mixing, hold-up volume, equipment train, operator practice, site systems, or material flow may change process behavior.	Transfer protocol, comparability assessment, PPQ, cleaning study, analytical bridging, and CPV plan.
Cleaning process or product matrix change	New residue, potency, solubility, equipment surface, detergent, cycle, or campaign pattern may invalidate the previous cleaning rationale.	Cleaning risk assessment, recovery work, visual limits, analytical testing, and targeted or full cleaning validation.
Repeated deviation, OOS, or OOT	Recurring failures or adverse trends may show that the process is not robust, even if individual batches were released.	Root-cause investigation, trend analysis, CAPA, additional sampling, and process or method revalidation.
Major repair, breakdown, or extended shutdown	Internal parts, sensors, seals, software, utilities, lubrication, or control loops may no longer match the qualified state.	Maintenance record, impact assessment, calibration, functional tests, requalification, and post-repair verification.
Software, recipe, or data-system change	Changes to control logic, calculations, audit trails, interfaces, user roles, or reporting can affect process execution or data integrity.	CSV/CSA impact assessment, regression tests, access review, audit-trail review, and system requalification.
New regulatory or scientific knowledge	Updated expectations, a new impurity concern, revised toxicological limit, or improved analytical knowledge may change the control strategy.	Regulatory gap assessment, risk review, method update, additional studies, or revised validation strategy.
Periodic review finding	Annual or scheduled review may identify drift, emerging risk, overdue actions, weak capability, or incomplete historical evidence.	Periodic review report, CPV metrics, deviation/CAPA history, complaints, changes, and revalidation plan.

What Does Not Automatically Require Full Revalidation?

Not every change deserves a complete repeat of the original study. A low-risk administrative update, like-for-like replacement, typographical correction, or routine calibration adjustment may be controlled through documented assessment and verification. The conclusion must be based on evidence, not on the label “minor.”

Like-for-like part

A replacement sensor or seal may need calibration and functional verification rather than full process revalidation when specifications, material, range, location, and control function are equivalent.

Document-only revision

A formatting change or clarified instruction may not affect validation if the operation, acceptance criteria, responsibilities, and data remain unchanged.

Routine maintenance

Preventive maintenance within approved instructions can be followed by normal post-maintenance checks when no validated parameter or equipment function is changed.

Trend without impact

A statistical signal may require investigation and increased monitoring while the process remains within validated requirements. Revalidation follows only when the risk assessment supports it.

Equivalent test method

A method change may be bridged through analytical validation or comparability when the intended use, performance characteristics, and data interpretation remain equivalent.

Planned periodic review

A scheduled review is an assessment point. It does not automatically mean a full repeat of PPQ, cleaning validation, or qualification.

Never use “no impact” as a conclusion without a reason. Record the affected requirement, the data reviewed, the quality-risk rationale, the verification performed, and the QA approval.

Risk-Based Revalidation Decision Framework

A good decision framework links the event to the original validation basis. Start with the intended use and critical quality attributes, then evaluate what changed, how the change could propagate, and whether existing controls can detect or prevent the risk.

Describe the event

Capture the change, deviation, failure, repair, transfer, trend, complaint, or regulatory input in a controlled record.

Map the scope

Identify products, batches, equipment, utilities, rooms, methods, software, data, and documents that may be affected.

Compare the baseline

Compare the current state with the approved URS, design, process description, control strategy, qualification, and validation reports.

Assess risk

Evaluate severity, occurrence, detectability, uncertainty, patient impact, and the effectiveness of existing controls.

Choose evidence

Select document review, calibration, functional testing, sampling, targeted qualification, PPQ, method validation, or full revalidation.

Approve the plan

Route the decision through change control, deviation, CAPA, or periodic review with QA approval before execution.

Execute and review

Follow an approved protocol, preserve raw data, investigate deviations, and compare results with predefined criteria.

Restore control

Issue the report, update procedures and training, revise monitoring, close actions, and confirm the validated state.

Decision logic at a glance

Event identifiedImpact assessmentRisk-ranked scopeEvidence planQA approvalRevalidation or justified verificationReport and lifecycle update

For the quality-risk method, align the assessment with ICH Quality Guidelines and current quality-risk principles. The site procedure should define when an issue becomes a formal CAPA or requires escalation under the quality system.

Revalidation of Pharmaceutical Processes

Process revalidation demonstrates that the manufacturing process still delivers product within approved specifications and critical quality attributes. It should consider the process design, critical material attributes, critical process parameters, in-process controls, sampling plan, equipment train, operator practices, and continued process verification data.

Common process-revalidation situations

A new formulation, strength, API source, polymorph, excipient grade, or material supplier changes the process risk.
Batch size, fill volume, equipment train, speed range, mixing geometry, dryer load, or compression tooling changes outside the validated range.
Repeated deviations, OOS results, OOT trends, complaints, yield drift, dissolution shift, blend-uniformity variability, or stability signals question process capability.
Technology transfer or site change introduces different utilities, room classifications, equipment, automation, raw-material handling, or operator practices.
A control strategy, in-process test, sampling location, process endpoint, or analytical method is changed in a way that can affect release decisions.

PPQ is not the only evidence. Depending on the risk, a revalidation package can include engineering batches, targeted challenge runs, process capability, continued process verification, enhanced sampling, and updated control limits. The protocol should explain why the selected evidence is sufficient.

What should be trended after revalidation?

Data stream	Examples	Why it matters
Process parameters	Temperature, pressure, speed, mixing time, endpoint, flow, compression force, coating rate.	Shows whether the process remains inside the qualified operating space.
In-process attributes	Moisture, weight variation, blend uniformity, viscosity, pH, particle size, hardness.	Detects early drift before finished-product failure.
Finished-product results	Assay, impurities, dissolution, microbial quality, sterility, content uniformity, yield.	Confirms the patient-relevant output remains predictable.
Quality events	Deviations, OOS/OOT, complaints, rejects, rework, CAPA, change controls.	Connects isolated events to systemic signals.
Capability indicators	Control charts, Cp/Cpk or Ppk where appropriate, run rules, confidence intervals, and trend limits.	Quantifies process stability and ability to meet requirements.

Equipment Requalification and Facility Revalidation

Equipment and facility changes can invalidate process evidence even when the recipe is unchanged. A new impeller, vessel, filter housing, sensor, PLC, filling needle, HVAC component, water loop, or room configuration may change heat transfer, flow, mixing, pressure, microbial control, or data capture.

Design impact

Confirm that the updated equipment or facility still meets the approved URS and design intent. Review materials of construction, capacity, contact surfaces, alarms, and control functions.

Installation impact

Use targeted or full IQ evidence for location, utilities, instruments, components, drawings, calibration status, and identification.

Operating impact

Use OQ tests to challenge alarms, ranges, interlocks, controls, recipes, automation, and operating limits affected by the change.

Performance impact

Use PQ or process-performance evidence to show that the equipment performs effectively with the real product, load, operators, and routine conditions.

Design review

When a new asset or major modification is introduced, document the DQ rationale before procurement or installation.

Maintenance and calibration

Use preventive maintenance, calibration, alarm review, and post-repair verification to support the qualified state and to identify when requalification is necessary.

The key question is not whether the asset has the same nameplate. It is whether the change can affect the validated function, critical parameter range, product-contact surface, contamination control, or data integrity. Link qualification evidence to the affected process and to the applicable SOP.

Cleaning Revalidation: When It Is Needed

Cleaning validation should be reassessed when the residue challenge, equipment configuration, cleaning chemistry, cycle, or campaign pattern changes. A documented visual inspection alone may not support a new worst-case product or a new equipment train.

Cleaning trigger	Potential impact	Typical response
New product or strength	Different potency, toxicity, solubility, dose, cleanability, or residue limit.	Update risk assessment and MACO/HBEL rationale; run targeted or full cleaning validation as justified.
New equipment or surface	Changed geometry, surface finish, dead legs, gasket, spray coverage, or drainage.	Equipment impact assessment, visual coverage, rinse/swab recovery, and cleaning-cycle evidence.
Detergent or cycle change	Different concentration, temperature, contact time, flow, sequence, or rinse endpoint.	Challenge the revised cycle and verify residue removal, microbiological control, and chemical limits.
Repeated cleaning failure	Indicates the existing process may not be robust for the product or equipment matrix.	Investigate root cause, implement CAPA, revise the cycle, and revalidate affected scenarios.
Extended campaign or dirty hold	Residue may dry, harden, react, or support microbial growth before cleaning.	Reassess dirty hold time and cleaning validation under the longest justified conditions.

Use the site's approved CAPA process whenever a cleaning trend or failure indicates a systemic control gap. Cleaning revalidation should also preserve ALCOA+ expectations for sample identity, instrument data, calculations, integrations, review, and approval.

Analytical Method and Computerized-System Revalidation

Analytical methods and computerized systems have their own validated state. A process change can increase the need for method revalidation if the matrix, concentration, impurity profile, sample preparation, or reporting range changes. A software update can require revalidation if it changes calculations, interfaces, user privileges, audit trails, recipe logic, data retention, or electronic signatures.

Analytical method trigger

New strength, formulation, impurity, sample matrix, instrument, column, detector, range, or specification may require partial or full method validation.

Instrument trigger

Replacement, firmware change, detector change, relocation, major repair, or changed data system can require qualification, calibration, and method impact testing.

Software trigger

Recipe, PLC, MES, LIMS, ERP, or instrument software changes should be assessed for functional, security, audit-trail, interface, and data-integrity impact.

Data-integrity trigger

Unexplained audit-trail activity, access-control failure, missing raw data, calculation error, or backup weakness may require system review and revalidation.

Electronic-record control

Where applicable, assess 21 CFR electronic records, signatures, audit trails, security, and retention expectations.

Evidence quality

Use controlled test scripts, approved expected results, independent review, traceability, and secure raw data rather than screenshots alone.

Periodic Review and Continued Verification

A periodic review is a structured health check of the validated state. It normally reviews changes, deviations, OOS/OOT, complaints, recalls, CAPA, maintenance, calibration, environmental monitoring, CPV, stability, cleaning results, audit findings, and regulatory commitments. The output can be “no action,” enhanced monitoring, targeted requalification, or a revalidation plan.

Periodic-review questions

Have any critical process parameters or critical quality attributes shown a statistically meaningful drift?
Were there recurring deviations, OOS/OOT results, complaints, rejects, rework, or unexplained yield changes?
Did equipment, utilities, rooms, instruments, software, suppliers, materials, or cleaning cycles change?
Are calibration, preventive maintenance, environmental monitoring, and alarm records current and acceptable?
Are validation protocols, reports, data, raw records, and approvals complete and retrievable?
Has new regulatory, pharmacopoeial, toxicological, or scientific information changed the risk?
Are established hold times, storage conditions, sampling plans, and acceptance criteria still justified?
Does the original validation represent current batch size, product mix, site, equipment, and operating practice?

Periodic review is not a shortcut. If the review identifies a material gap, the conclusion should open a controlled change, deviation, CAPA, or revalidation protocol with clear due dates and ownership.

Revalidation Protocol: Required Contents

A revalidation protocol should be concise enough to execute and detailed enough to prevent interpretation during testing. It should identify what changed, why the original validation may be affected, what evidence will close the uncertainty, and which predefined criteria determine success.

Protocol element	Practical content
Title, identifier, and revision	Unique protocol number, version, product/system name, site, effective date, and linked change/deviation/CAPA number.
Objective and scope	State the trigger, affected system, products, batches, equipment, rooms, methods, software, and exclusions.
Background and baseline	Reference the approved validation, qualification, control strategy, requirements, prior reports, and current-state comparison.
Risk assessment	Explain severity, likelihood, detectability, uncertainty, patient impact, and why the selected scope is proportionate.
Responsibilities and training	Assign Production, QC, QA, Validation, Engineering, IT, Microbiology, Warehouse, and document-review roles.
Materials, equipment, and conditions	Define batch size, raw materials, equipment configuration, utilities, room, environmental conditions, software version, and operators.
Test matrix and sampling	List samples, locations, time points, replicates, sample quantities, methods, chain of custody, and data review.
Acceptance criteria	Set objective limits for CQAs, CPPs, qualification checks, cleaning residues, microbial attributes, data integrity, and statistical outputs.
Deviation and change handling	Explain how unexpected results, excursions, missing data, invalid tests, and protocol changes will be assessed.
Approval and report plan	Define who approves the protocol, who reviews raw data, how the report is issued, and how the validated state is restored.

Executing and Reviewing Revalidation Studies

Execution should follow the approved protocol and the current SOP. Any departure should be documented at the time it occurs. Backdating, informal substitution of samples, undocumented parameter adjustment, or selective reporting can make an otherwise technically sound study unreliable.

Execution controls

Confirm equipment, instruments, utilities, calibration, preventive maintenance, materials, and operators are ready before the run.
Verify the correct protocol revision, approved forms, sampling tools, test methods, calculations, and labels are available.
Record actual values, not only pass/fail statements; capture start/stop times, interventions, alarms, holds, and environmental conditions.
Maintain traceability from batch and sample number through laboratory result, raw data, calculation, review, and final conclusion.
Review original electronic data, audit trails, metadata, integrations, and calculations where computerized systems are used.
Investigate every unexpected result before concluding that the study passed or failed.

Revalidation report conclusions

The final report should explain whether the affected system remains validated, whether restrictions apply, and what follow-up controls are required. Avoid a vague conclusion such as “all results are satisfactory.” State the evidence, the limitations, the deviations, the statistical or scientific rationale, and the exact effective date of the revised validated state.

Validated state after review = approved baseline + assessed change + objective evidence + QA-approved conclusionThe formula is a practical decision model, not a regulatory calculation. All four elements should be traceable in the quality system.

Deviation, OOS, and CAPA During Revalidation

A revalidation failure is not automatically a product failure, but it is always a quality event that needs a documented assessment. The investigation should separate protocol execution error, laboratory error, equipment malfunction, process cause, sampling limitation, and genuine product or system performance failure.

Containment

Place affected batches, equipment, data, or materials under controlled status while the potential impact is assessed.

Evidence preservation

Secure raw data, audit trails, instrument files, samples, logbooks, alarms, maintenance records, and environmental records.

Root cause

Use evidence-based investigation tools to determine whether the cause is procedural, equipment-related, analytical, material-related, human, or systemic.

Product impact

Assess affected batches, time period, equipment train, markets, stability, release decisions, and patient risk using approved procedures.

Corrective action

Repair, retrain, revise the method, restore controls, or repeat testing only when scientifically justified and allowed by procedure.

Effectiveness

Confirm that the corrective and preventive actions prevent recurrence through monitoring, targeted studies, or a subsequent revalidation run.

Use the newer CAPA workflow for systemic issues and retain the historical CAPA reference where your site procedure uses it. Data and conclusions should follow ALCOA+ principles.

Practical Revalidation Examples

Scenario	Initial decision	Likely evidence	Final control
Tablet press replaced with a different turret and feeder design	High impact because tooling, feed behavior, compression force, and dwell time may change.	DQ/IQ/OQ review, calibration, engineering batches, targeted or full PQ/PPQ, content-uniformity and dissolution data.	Updated operating ranges, training, maintenance, and CPV trending.
Same HPLC model replaced with an equivalent detector	Potentially targeted; confirm range, sensitivity, software, column compatibility, and method performance.	Instrument qualification, system suitability, precision/accuracy or bridging, data-system review, and approved impact assessment.	Method and instrument records updated; no full process revalidation if equivalence is demonstrated.
New API supplier with a different particle-size distribution	High risk if flow, dissolution, blend uniformity, or compaction is sensitive to the attribute.	Material comparability, risk assessment, development data, blend/compaction study, PPQ or enhanced CPV.	Supplier controls, incoming specifications, process limits, and monitoring plan.
Recurring cleaning failure after an extended campaign	High impact; the prior worst-case and dirty-hold assumptions may be inadequate.	Root cause, dirty-hold challenge, revised cycle, recovery study, residue limits, and targeted/full cleaning validation.	Campaign limit, dirty hold limit, revised cleaning SOP, operator training, and CAPA effectiveness check.
HVAC fan replacement in a non-sterile weighing room	Assess airflow, pressure, temperature, humidity, particle control, and product exposure.	Commissioning, IQ/OQ, airflow and pressure tests, mapping, environmental monitoring, and affected-process impact assessment.	Updated drawings, alarm setpoints, maintenance plan, and room qualification status.
Manufacturing software update changes a batch calculation	High impact if the calculation affects dispensing, yield, release, or electronic records.	Change assessment, regression tests, access/audit-trail review, interface checks, backup/restore test, and CSV evidence.	Approved software version, controlled release, training, periodic review, and audit-trail monitoring.

Audit-Ready Revalidation Checklist

Use this checklist as a review aid; adapt it to the site's validation master plan and quality procedures.

Is the trigger documented in approved change control, deviation, CAPA, or periodic review?
Does the assessment identify affected products, batches, equipment, utilities, methods, software, and data?
Is the original validated baseline available, approved, and still representative?
Are critical quality attributes, critical process parameters, and acceptance criteria identified?
Was the risk assessment completed by appropriate subject-matter experts and approved by QA?
Does the selected evidence match the risk, including targeted testing where full repetition is unnecessary?
Were protocol, sampling plan, methods, forms, instruments, and training approved before execution?
Are actual observations, raw data, metadata, audit trails, calculations, and deviations complete?
Were unexpected results investigated before the final conclusion was written?
Does the report state the exact validated scope, limitations, restrictions, and effective date?
Were procedures, drawings, recipes, specifications, training, maintenance, calibration, and monitoring updated?
Is effectiveness or continued verification planned for the period after revalidation?

Where design or equipment requirements are affected, link the assessment to the approved DQ, IQ, OQ, and PQ evidence.

Key Takeaways

Revalidation is required when a change, failure, trend, transfer, repair, or new knowledge may affect the validated state.
A periodic review is a risk-based assessment point, not an automatic instruction to repeat every original study.
The scope may be no revalidation, targeted revalidation, requalification, analytical bridging, enhanced monitoring, or full revalidation.
Process, equipment, facility, utility, cleaning, analytical method, computerized system, and data-integrity changes can all trigger assessment.
The protocol must define objective acceptance criteria, representative sampling, responsibilities, deviations, and report approval before execution.
Revalidation does not replace continued process verification, preventive maintenance, calibration, change control, or CAPA effectiveness checks.
Every “no impact” conclusion needs a documented rationale and evidence that can withstand an inspection.

Conclusion

Revalidation in pharmaceuticals is required whenever the evidence supporting a validated state may no longer represent the current process, equipment, facility, method, software, or operating environment. The strongest programs identify triggers early, use quality risk management to set the scope, and connect change control, deviation management, CAPA, continued verification, qualification, and validation into one lifecycle.

A proportionate decision is more defensible than a calendar-driven ritual. It may be a documented no-impact assessment, a focused requalification, a targeted process study, or a full revalidation package. What matters is that the decision is scientifically justified, approved before execution, supported by complete data, and followed by controls that keep the process in a state of control.

Related Pharmaceutical Validation Guides

Use these internal guides to connect revalidation decisions with the rest of the pharmaceutical quality system:

Process ValidationLifecycle and evidence strategy ICH Quality GuidelinesRisk and quality framework CAPACorrective and preventive action ALCOA+Reliable validation evidence

Frequently Asked Questions

Is revalidation required every year?

No. A site may perform an annual or periodic review, but a full revalidation is required only when the review or another event shows that the validated state may be affected. The review frequency and scope should be justified by risk, process knowledge, history, and regulatory commitments.

What is the most common trigger for process revalidation?

Common triggers include significant process or formulation changes, scale-up, technology transfer, equipment replacement, recurring deviations, OOS/OOT trends, and evidence that a critical quality attribute or process parameter is drifting.

Does a major equipment repair require revalidation?

It requires an impact assessment. A repair that restores an equivalent function may need calibration and targeted qualification, while a repair that changes geometry, control logic, contact surfaces, capacity, or performance may require partial or full requalification and process revalidation.

Is requalification the same as revalidation?

No. Requalification concerns a facility, utility, equipment item, or system and its ability to meet approved requirements. Revalidation concerns a process, cleaning program, analytical method, or computerized system and its continued ability to achieve its intended outcome.

When does a deviation lead to revalidation?

A deviation leads to revalidation when the investigation identifies a systemic or unresolved cause that could affect the validated process or control strategy. A single isolated event may be managed through correction and verification if the risk assessment demonstrates that the validated state remains intact.

Can a risk assessment justify no revalidation?

Yes. A documented, technically sound assessment can conclude that no revalidation is needed when the change has no credible impact on critical requirements and suitable verification confirms equivalence. QA should approve the rationale and any follow-up monitoring.

What should a revalidation protocol include?

It should include the objective, scope, trigger, baseline, risk assessment, responsibilities, materials, equipment, conditions, sampling plan, methods, acceptance criteria, deviation handling, data review, report requirements, and approval signatures.

Does a new supplier automatically require process revalidation?

No, but the supplier change must be assessed. If the material attribute can affect blending, granulation, compression, dissolution, sterility, stability, or another critical outcome, the evidence may range from supplier qualification and comparability to targeted studies or full process-performance qualification.

How are computerized systems revalidated after an update?

Use a risk-based computerized-system change assessment. Review requirements, configured functions, calculations, interfaces, access, audit trails, electronic signatures, backup and restore, data migration, and regression tests. Revalidation scope should match the functions and records affected.

Who approves the final revalidation decision?

Quality Assurance normally owns or approves the final quality-system decision, with input from Validation, Production, QC, Engineering, IT, Microbiology, and other subject-matter experts as applicable. The approval should state whether the system is fully validated, conditionally accepted, restricted, or requires further action.

Ad Code